论文部分内容阅读
国家经委于不久前发出“关于加强省、市、自治区医药管理机构的通知”。通知内称:“中西药品和医疗器械的生产供应工作直接关系到各族人民防病治病、康复、保健和计划生育的成效,医药业务的管理工作也是相当繁重的,在经济调整中建立起来的产供销结合、工农商一体的医药统一管理新体制要继续推行。因此,在这次机构改革中、请各地按国务院国发[1981]87号‘国务院关于哪强医药管理的决定’,适当加强医药统一管理机构,省、市、自治区医药管理局(总公司)应予以健全充实,地(市)、县的医药机构也要相应加强,以保证工作的连续性、稳定性”。
Not long ago, the State Economic Commission issued the Notice on Strengthening the Administration of Pharmaceuticals in the Provinces, Municipalities and Autonomous Regions. The circular said: “The production and supply of medicines and medical devices between China and the West are directly related to the effectiveness of people of all nationalities in preventing and treating diseases, rehabilitation, health care and family planning. The management of the pharmaceutical business is also quite arduous and has been established in economic restructuring Therefore, in this institutional reform, please follow the guidelines issued by the State Council [1981] No.87, ”Decision of the State Council on Which Medical Management is Strong,“ and ” Appropriately strengthen the medical unified management agencies, provinces, municipalities and autonomous regions, the Medical Administration Bureau (head office) should be robust enrichment, prefectural (city) and county medical institutions should also be strengthened accordingly to ensure the continuity of work, stability.